TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma - Test2 - elhamkhani - TriplyDB

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

http://www.wikidata.org/entity/Q35871985

about

Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs Stem cells in genetically-engineered mouse models of prostate cancer Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents Targeting tumor-associated macrophages to combat pancreatic cancer Transforming growth factor β as regulator of cancer stemness and metastasis Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma Rapamycin enhances the antiproliferative effect of transforming growth factor-β on MCF-7 human breast cancer cells Targeting metastasis-initiating cells through the fatty acid receptor CD36.Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(∗) in SCC progression.MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties.Squamous Cell Cancers: A Unified Perspective on Biology and Genetics Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma.The Role of Pulmonary Veins in Cancer Progression from a Computed Tomography Viewpoint.Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.Calreticulin is highly expressed in pancreatic cancer stem-like cells.ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma.Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer.Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox.TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells.Suppression of skin tumorigenesis in CD109-deficient mice.Shrinkage-mediated imaging of entire organs and organisms using uDISCO.Search for Master Regulators in Walking Cancer Pathways.Keratoacanthoma: a distinct entity?Matters of context guide future research in TGFβ superfamily signaling.Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines Long-Lived Epidermal Cancer-Initiating Cells.Identifying drug resistant cancer cells using microbubble well arrays.Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.TIMPs: versatile extracellular regulators in cancer.RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.Preclinical Advances with Multiphoton Microscopy in Live Imaging of Skin Cancers.

P2860

Q26777335-F337188D-A89D-4E56-BA41-C1DFFCF004E6 Q26784057-A08FFB92-9DFF-4BC0-B374-AE5E084EAA6C Q28073524-F00A6515-9429-4658-BD0D-4F50E49BF18E Q28076103-2ECC4686-AC5E-4847-908D-28A98A869B82 Q28077319-CC9B0241-5D72-4ADE-8BD3-E849CA926655 Q33612711-A39B2E17-F7FE-44A8-8859-33F25C354239 Q33816188-7DF4532C-E9EA-4823-BD32-4172BBB5023A Q33847432-FB4EF9E2-F22B-489C-AC54-49393B66B4BE Q34547374-5F67F28D-3C95-4E1E-8341-67DB33AC7444 Q35855855-474B7476-D77B-4B23-B75C-11F10267F1EF Q36284814-0FF4EB7E-B202-42E2-B263-77A55E5DDBA5 Q36401950-B9206E5F-647B-4E50-B7F7-29CD973D6BF2 Q36539734-EC96ECA7-5BC5-457F-84DC-260DEF99DD6F Q36745073-043BDC9B-2EE3-457A-A22B-A7FECB82B8D1 Q36909843-0D232EB6-D049-43D7-8B3E-834E06F7637B Q36951822-96CE11FD-252D-401F-9531-C48BA299A919 Q36964214-F8099FB5-D17D-4408-8CD9-80D7CDF369F6 Q37063904-1622BBA1-C602-40FC-8332-F8E227BB3C25 Q37121524-BA08DC3D-CA51-4340-9B10-D49F3BEEB4C1 Q37322683-2C3A7AE8-B119-4F61-8D21-13477AD45622 Q37397455-1EAD5D79-9597-4734-A75F-50573701AC8C Q37462512-20A22BAA-C3B3-48C1-87BF-792AEC85BCAF Q37465944-1EE5B866-2C12-40CA-8B61-A3AB51332B2A Q37526007-8FF5F2BF-6D70-4CA1-AA70-618485C0D0AE Q37628185-BCD61AE4-3D44-4051-898D-5EBF5D6B774D Q37693688-9E870E17-CDA1-4E94-AFE6-EC33A9A9274D Q37696223-E48889D2-F9E5-4235-AAFB-380CACE4CB1F Q38378693-BDC74CA3-3CA9-4166-8AA6-E51C41742E1C Q38604272-DDF93886-BC0E-4D0E-A7BC-1F1BF4E1CD09 Q38609786-0315C53B-9913-45C8-96E2-C4F7C5595445 Q38612468-67BBC701-E455-4D37-B975-5C5BD7DA8358 Q38647100-A35BC998-CD52-4954-A088-230C35981060 Q38707291-37D6ED44-2451-496A-8D6B-363EB7265998 Q38709641-74C415D7-6F48-4816-8062-EFB401D5DBC5 Q38724559-286AB952-0BB9-4D84-9E62-8B039F2BC4B2 Q38760598-8406EF70-0774-472C-9018-FA9EEBD6CD02 Q38762901-A4AB3CCE-C52C-4AAA-AD53-55CC123BC070 Q38785433-26542076-3D75-4832-B1CC-F8CD88EDFF0C Q38790417-4AF94B3D-C4D2-44C4-B6C1-C75502112D04 Q38795140-A3B93866-F0B5-4855-B0CE-034DC3983D77

P2860

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

http://www.wikidata.org/entity/Q35871985

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@ast

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@en

type

label

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@ast

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@en

prefLabel

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@ast

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@en

P1433

Q35871985-F628779E-FCB5-4569-BFDB-F8CD232522EC

P1476

Q35871985-05EECEBA-8846-45CF-85FA-AFC6D1637C03

P2093

Q35871985-0572FADD-2F89-4949-8701-57C3BDB75464

Q35871985-FBC6F965-8C16-4E16-A531-9DBB233CE31A

P2860

Q35871985-02BBF704-1022-4822-9435-D8835673D2F4

Q35871985-0F0B56DC-563E-4F5F-A96E-ADFF0B593B92

Q35871985-17DDB18C-B572-4A77-9BC6-95ADC67573B6

Q35871985-1E77452C-1E41-4DB4-A592-DD118A987084

Q35871985-1EAF3D36-C393-4D92-BD5B-AD572B5F601A

Q35871985-1F12F331-651F-476A-977E-01D1CEA1172A

Q35871985-2A95A379-4A3F-495A-8376-E63670AA47A6

Q35871985-2D75AB14-B182-465A-817B-44666D11EB5D

Q35871985-3627BCE1-1247-4000-B9C6-A6961965E355

Q35871985-42A4A7B4-A37F-4743-921D-E24C3680A698

P304

Q35871985-A4B470BF-D954-48B8-8EC2-E63A7EBA26A9

P31

Q35871985-9AE641D7-36CC-4ED7-88B0-906253E55BF2

P356

Q35871985-71606514-0C09-435A-8C3B-3FD88D197EA5

P407

Q35871985-DF9E9302-B056-4E3E-BEFD-2CECC350245E

P433

Q35871985-A58136AA-6AB3-4280-BBED-AB765653BA73

P478

Q35871985-1FE77117-FAD8-4806-AAE3-584DEF5CC87F

P50

Q35871985-60410CBD-F5E0-4BA1-A9C1-570B7515F082

P577

Q35871985-FD110937-B5AE-4967-9B35-15A22C22DDDB

P698

Q35871985-E275AE5F-6738-4881-93A6-1E6883FE4CC3

P932

Q35871985-7F9399E8-6D41-400A-BA7C-A98395452255

P356

J.CELL.2015.01.043

P1433

P1476

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

@en

P2093

Daniel Oristian

http://www.w3.org/2001/XMLSchema#string

Naoki Oshimori

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response

Mammary stem cells and the differentiation hierarchy: current status and perspectives

Immunity, Inflammation, and Cancer

Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation

E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression

TGFβ signalling in context

Smad transcription factors

Master transcription factors determine cell-type-specific responses to TGF-β signaling

Clonal evolution in cancer

P304

963-976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2015.01.043

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25723170

http://www.w3.org/2001/XMLSchema#string

P932

4509607

http://www.w3.org/2001/XMLSchema#string